| 1. |
|
|
| 2. |
- Engert, Andreas, et al.
(författare)
-
The European Hematology Association Roadmap for European Hematology Research : a consensus document
- 2016
-
Ingår i: Haematologica. - Pavia, Italy : Ferrata Storti Foundation (Haematologica). - 0390-6078 .- 1592-8721. ; 101:2, s. 115-208
-
Tidskriftsartikel (refereegranskat)abstract
- The European Hematology Association (EHA) Roadmap for European Hematology Research highlights major achievements in diagnosis and treatment of blood disorders and identifies the greatest unmet clinical and scientific needs in those areas to enable better funded, more focused European hematology research. Initiated by the EHA, around 300 experts contributed to the consensus document, which will help European policy makers, research funders, research organizations, researchers, and patient groups make better informed decisions on hematology research. It also aims to raise public awareness of the burden of blood disorders on European society, which purely in economic terms is estimated at (sic)23 billion per year, a level of cost that is not matched in current European hematology research funding. In recent decades, hematology research has improved our fundamental understanding of the biology of blood disorders, and has improved diagnostics and treatments, sometimes in revolutionary ways. This progress highlights the potential of focused basic research programs such as this EHA Roadmap. The EHA Roadmap identifies nine 'sections' in hematology: normal hematopoiesis, malignant lymphoid and myeloid diseases, anemias and related diseases, platelet disorders, blood coagulation and hemostatic disorders, transfusion medicine, infections in hematology, and hematopoietic stem cell transplantation. These sections span 60 smaller groups of diseases or disorders. The EHA Roadmap identifies priorities and needs across the field of hematology, including those to develop targeted therapies based on genomic profiling and chemical biology, to eradicate minimal residual malignant disease, and to develop cellular immunotherapies, combination treatments, gene therapies, hematopoietic stem cell treatments, and treatments that are better tolerated by elderly patients.
|
|
| 3. |
- Brodin, Daniel, et al.
(författare)
-
Inhaled ciclesonide in adults hospitalised with COVID-19 : a randomised controlled open-label trial (HALT COVID-19)
- 2023
-
Ingår i: BMJ Open. - : BMJ Publishing Group Ltd. - 2044-6055. ; 13:2
-
Tidskriftsartikel (refereegranskat)abstract
- OBJECTIVE: To assess the efficacy of inhaled ciclesonide in reducing the duration of oxygen therapy (an indicator of time to clinical improvement) among adults hospitalised with COVID-19.DESIGN: Multicentre, randomised, controlled, open-label trial.SETTING: 9 hospitals (3 academic hospitals and 6 non-academic hospitals) in Sweden between 1 June 2020 and 17 May 2021.PARTICIPANTS: Adults hospitalised with COVID-19 and receiving oxygen therapy.INTERVENTION: Inhaled ciclesonide 320 µg two times a day for 14 days versus standard care.MAIN OUTCOME MEASURES: Primary outcome was duration of oxygen therapy, an indicator of time to clinical improvement. Key secondary outcome was a composite of invasive mechanical ventilation/death.RESULTS: Data from 98 participants were analysed (48 receiving ciclesonide and 50 receiving standard care; median (IQR) age, 59.5 (49-67) years; 67 (68%) men). Median (IQR) duration of oxygen therapy was 5.5 (3-9) days in the ciclesonide group and 4 (2-7) days in the standard care group (HR for termination of oxygen therapy 0.73 (95% CI 0.47 to 1.11), with the upper 95% CI being compatible with a 10% relative reduction in oxygen therapy duration, corresponding to a <1 day absolute reduction in a post-hoc calculation). Three participants in each group died/received invasive mechanical ventilation (HR 0.90 (95% CI 0.15 to 5.32)). The trial was discontinued early due to slow enrolment.CONCLUSIONS: In patients hospitalised with COVID-19 receiving oxygen therapy, this trial ruled out, with 0.95 confidence, a treatment effect of ciclesonide corresponding to more than a 1 day reduction in duration of oxygen therapy. Ciclesonide is unlikely to improve this outcome meaningfully.TRIAL REGISTRATION NUMBER: NCT04381364.
|
|
| 4. |
- Abdellah, Tebani, et al.
(författare)
-
Integration of molecular profiles in a longitudinal wellness profiling cohort.
- 2020
-
Ingår i: Nature communications. - : Springer Science and Business Media LLC. - 2041-1723. ; 11:1
-
Tidskriftsartikel (refereegranskat)abstract
- An important aspect of precision medicine is to probe the stability in molecular profiles among healthy individuals over time. Here, we sample a longitudinal wellness cohort with 100 healthy individuals and analyze blood molecular profiles including proteomics, transcriptomics, lipidomics, metabolomics, autoantibodies andimmune cell profiling, complementedwith gut microbiota composition and routine clinical chemistry. Overall, our results show high variation between individuals across different molecular readouts, while the intra-individual baseline variation is low. The analyses show that each individual has a unique and stable plasma protein profile throughout the study period and that many individuals also show distinct profiles with regards to the other omics datasets, with strong underlying connections between the blood proteome and the clinical chemistry parameters. In conclusion, the results support an individual-based definition of health and show that comprehensive omics profiling in a longitudinal manner is a path forward for precision medicine.
|
|
| 5. |
|
|
| 6. |
- Adegoke, Olutayo, 1979-, et al.
(författare)
-
Influence of laser powder bed fusion process parameters on the microstructure and cracking susceptibility of nickel-based superalloy Alloy 247LC
- 2022
-
Ingår i: Results in Materials. - : Elsevier. - 2590-048X. ; 13
-
Tidskriftsartikel (refereegranskat)abstract
- Microstructures of material conditions of nickel-based superalloy Alloy 247LC fabricated using laser powder bed fusion (L-PBF) were investigated. Experiments designed in a prior study revealed the L-PBF process parameters for which the material conditions displayed a reduced susceptibility to cracking. Certain process parameters produced material conditions with an increased susceptibility to cracking. In this study, the material conditions were investigated in detail to reveal their microstructure and to determine the cause of cracking. The reason for the transition between a reduced to an increased susceptibility to cracking was examined. The results revealed solidification cracking occurred at high-angle grain boundaries. Solidification cracking may have been promoted at high-angle grain boundaries because of the undercooling contribution of the grain boundary energy. Furthermore, Si segregation was observed in the cracks. Thus, the presence of Si most likely promoted solidification cracking. It was observed that a high crack density, which occurred in the high energy density material condition, was associated with a large average grain size. The fact that certain combination of process parameters produced microstructures with a low susceptibility to cracking, indicates that reliable Alloy 247LC material may be printed using L-PBF by employing improved process parameters. © 2022
|
|
| 7. |
- Adegoke, Olutayo, 1979-, et al.
(författare)
-
Influence of laser powder bed fusion process parameters on the microstructure of solution heat-treated nickel-based superalloy Alloy 247LC
- 2022
-
Ingår i: Materials Characterization. - : Elsevier. - 1044-5803 .- 1873-4189. ; 183
-
Tidskriftsartikel (refereegranskat)abstract
- In this study, Alloy 247LC samples were built with different laser powder bed fusion (L-PBF) process parameters. The samples were then subjected to solution heat treatment at 1260 °C for 2 h. The grain size of all the samples increased significantly after the heat treatment. The relationship between the process parameters and grain size of the samples was investigated by performing a design of experiment analysis. The results indicated that the laser power was the most significant process parameter that influenced the grain height and aspect ratio. The laser power also significantly influenced the grain width. The as-built and as-built + heat-treated samples with high, medium, and low energy densities were characterized using a field emission gun scanning electron microscope equipped with an electron backscatter diffraction detector. The micrographs revealed that the cells present in the as-built samples disappeared after the heat treatment. Isolated cases of twinning were observed in the grains of the as-built + heat-treated samples. The disappearance of cells, increase in the grain size, and appearance of twins suggested that recrystallization occurred in the alloy after the heat treatment. The occurrence of recrystallization was confirmed by analyzing the grain orientation spread of the alloy, which was lower and more predominantly <1° in the as-built + heat-treated conditions than in the as-built conditions. The microhardness of the as-built + heat-treated samples were high which was plausible because γ’ precipitates were observed in the samples. However, the L-PBF process parameters had a very low correlation with the microhardness of the as-built + heat-treated samples.
|
|
| 8. |
- Adegoke, Olutayo, et al.
(författare)
-
Scanning electron microscopy and atom probe tomography characterization of laser powder bed fusion precipitation strengthening nickel-based superalloy
- 2023
-
Ingår i: Micron. - 0968-4328 .- 1878-4291. ; 171
-
Tidskriftsartikel (refereegranskat)abstract
- Atom probe tomography (APT) was utilized to supplement scanning electron microscopy (SEM) characterizationof a precipitation strengthening nickel-based superalloy, Alloy 247LC, processed by laser powder bed fusion (LPBF). It was observed that the material in the as-built condition had a relatively high strength. Using both SEMand APT, it was concluded that the high strength was not attributed to the typical precipitation strengtheningeffect of γ’. In the absence of γ’ it could be reasonably inferred that the numerous black dots observed in thecells/grains with SEM were dislocations and as such should be contributing significantly to the strengthening.Thus, the current investigation demonstrated that relatively high strengthening can be attained in L-PBF even inthe absence of precipitated γ’. Even though γ’ was not precipitated, the APT analysis displayed a nanometer scalepartitioning of Cr that could be contributing to the strengthening. After heat-treatment, γ’ was precipitated and itdemonstrated the expected high strengthening behavior. Al, Ta and Ti partitioned to γ’. The strong partitioningof Ta in γ’ is indicative that the element, together with Al and Ti, was contributing to the strain-age crackingoccurring during heat-treatment. Cr, Mo and Co partitioned to the matrix γ phase. Hf, Ta, Ti and W were found inthe carbides corroborating previous reports that they are MC.
|
|
| 9. |
|
|
| 10. |
- Björnqvist, Anton, 1995-, et al.
(författare)
-
Identifying Teamwork Processes in a Medical Command and Control Team During the COVID-19 Pandemic
- 2023
-
Ingår i: Proceedings of the 20th International ISCRAM Conference. - Omaha, USA. ; , s. 711-720
-
Konferensbidrag (refereegranskat)abstract
- This paper presents an ethnographic study consisting of non-participatory observations of a Swedish regional medical command and control team during their crisis response to the COVID-19 pandemic. The field-notes from the observations were analyzed using a deductive content analysis with categories representing teamwork processes. The content analysis showed that the studied regional medical command and control team was engaged in all but one of the predefined teamwork processes. Furthermore, the content analysis also added to the understanding of the regional medical command and control teamÂ’s work procedures by emphasizing how the team was engaged in the different processes. Lastly, the content analysis also made it possible to identify potential developmental needs of the studied regional medical command and control team.
|
|
